Nuveen Asset Management, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$3,610,926
-16.2%
167,716
+4.8%
0.00%0.0%
Q1 2024$4,311,369
-12.0%
160,036
-2.1%
0.00%
-50.0%
Q4 2023$4,897,668
+57.6%
163,419
+7.7%
0.00%
+100.0%
Q3 2023$3,107,944
+1.3%
151,681
-1.8%
0.00%0.0%
Q2 2023$3,068,823
+116852.1%
154,445
+0.8%
0.00%0.0%
Q1 2023$2,624
-73.4%
153,223
-69.6%
0.00%
-75.0%
Q4 2022$9,858
-99.7%
503,721
+116.8%
0.00%
+100.0%
Q3 2022$3,709,000
-25.0%
232,389
-35.4%
0.00%0.0%
Q2 2022$4,947,000
+14.4%
359,540
+25.7%
0.00%
+100.0%
Q1 2022$4,325,000
+30.8%
286,049
+88.9%
0.00%0.0%
Q4 2021$3,306,000
-34.8%
151,439
-10.7%
0.00%
-50.0%
Q3 2021$5,069,000
-58.2%
169,578
-38.1%
0.00%
-50.0%
Q2 2021$12,132,000
+26.9%
273,929
+27.1%
0.00%
+33.3%
Q1 2021$9,564,000
+116.6%
215,554
+56.4%
0.00%
+200.0%
Q4 2020$4,415,000
-31.3%
137,840
-50.9%
0.00%
-50.0%
Q3 2020$6,423,000
-16.1%
280,964
-23.1%
0.00%
-33.3%
Q2 2020$7,651,000
+83.6%
365,531
+22.3%
0.00%
+50.0%
Q1 2020$4,168,000
+66.6%
298,777
+171.7%
0.00%
+100.0%
Q4 2019$2,502,000
+106.9%
109,947
+5.9%
0.00%
Q3 2019$1,209,000
-25.9%
103,818
-4.5%
0.00%
-100.0%
Q2 2019$1,631,000108,6920.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders